Verisk vs Teradyne
Anbieter von Risikodaten und Analysen für Versicherungen und Energie vs Anbieter von Halbleiter-Testsystemen und Industrierobotik. Welche Aktie passt im September 2026 besser zu Ihrem Portfolio? Die Antwort in einfacher Sprache finden Sie unten.
Movado sells Swiss-made watches and licensed fashion timepieces through department stores and its own boutiques, relying on brand positioning and gifting occasions to drive a relatively modest but profitable revenue base, while Waldencast is a beauty and wellness platform that acquired Obagi Medical and Milk Makeup to build a portfolio of prestige skincare and cosmetics brands. Both companies sell premium consumer products where brand equity is the primary economic asset and wholesale channel relationships determine reach. Movado vs Waldencast shows how an established watch brand with consistent cash generation compares to a newer beauty platform still integrating acquisitions and building its direct-to-consumer engine.
Movado sells Swiss-made watches and licensed fashion timepieces through department stores and its own boutiques, relying on brand positioning and gifting occasions to drive a relatively modest but pro...
Was den Kurs bewegt
Verisk is drawing support from a clean earnings beat, steady guidance, and a fresh dividend signal.
- Verisk’s latest quarter showed adjusted EPS of $1.98 on revenue of $806.3 million, a modest beat that suggests the business is still delivering steady, low-volatility growth.
- The company kept full-year 2026 EPS guidance at $7.45 to $7.75, reinforcing the view that management sees demand holding up rather than fading after the last report.
- A newly announced $0.50 quarterly dividend, payable later this month, is adding to the stock’s defensive appeal as investors look for stable cash generation.
Teradyne’s rally is losing momentum as investors question how much upside is left after a strong run.
- Teradyne has been sliding even after a strong quarterly report, suggesting investors are taking profits and reassessing how much of the AI and semiconductor demand story is already priced in.
- The company’s recent product launch for three new UltraFLEXplus AI test instruments points to continued demand in advanced chip testing, but the market appears focused on whether that growth can keep accelerating.
- A recent analyst downgrade to Hold and broader caution around the stock’s sharp year-to-date run have added to the pressure, fueling the view that TER may have limited room for error.
Verisk is drawing support from a clean earnings beat, steady guidance, and a fresh dividend signal.
- Verisk’s latest quarter showed adjusted EPS of $1.98 on revenue of $806.3 million, a modest beat that suggests the business is still delivering steady, low-volatility growth.
- The company kept full-year 2026 EPS guidance at $7.45 to $7.75, reinforcing the view that management sees demand holding up rather than fading after the last report.
- A newly announced $0.50 quarterly dividend, payable later this month, is adding to the stock’s defensive appeal as investors look for stable cash generation.
Teradyne’s rally is losing momentum as investors question how much upside is left after a strong run.
- Teradyne has been sliding even after a strong quarterly report, suggesting investors are taking profits and reassessing how much of the AI and semiconductor demand story is already priced in.
- The company’s recent product launch for three new UltraFLEXplus AI test instruments points to continued demand in advanced chip testing, but the market appears focused on whether that growth can keep accelerating.
- A recent analyst downgrade to Hold and broader caution around the stock’s sharp year-to-date run have added to the pressure, fueling the view that TER may have limited room for error.
Anlageanalyse
Verisk
VRSK
Vorteile
- Verisk maintains a leading position in insurance data analytics with advanced AI and cloud-based solutions.
- The company demonstrates consistent revenue growth, supported by a robust subscription model and strong profit margins.
- Verisk is expanding internationally and into new segments through strategic acquisitions and product innovation.
Zu beachten
- Recent financial results have been mixed, with net income declining and FY25 sales guidance cut below estimates.
- Valuation metrics are elevated compared to sector averages, with a high P/E and price-to-sales ratio.
- The business faces execution risks from integrating recent acquisitions and evolving from a utility to a technology network.
Teradyne
TER
Vorteile
- Teradyne benefits from strong demand in semiconductor and electronics testing, driven by global technology trends.
- The company has a diversified product portfolio and a solid track record of innovation in automation solutions.
- Teradyne maintains healthy margins and a resilient business model, supported by recurring revenue streams.
Zu beachten
- Revenue and earnings are sensitive to semiconductor industry cycles, exposing Teradyne to cyclical downturns.
- The company faces intense competition from larger rivals and emerging players in the automation and testing space.
- Recent acquisitions have increased leverage, raising concerns about integration risks and return on capital.
Verisk (VRSK) – Nächster Termin für Quartalszahlen
The next expected earnings date for VRSK is October 28, 2026, with the earnings call typically following the company’s quarterly reporting schedule. This report should cover fiscal Q3 2026. If the company changes timing, the date could shift slightly, but late October is the current expected window.
Teradyne (TER) – Nächster Termin für Quartalszahlen
TER’s next earnings date is expected on October 27, 2026. This report should cover Q3 2026. The date is currently an estimated release window based on the company’s historical reporting pattern, since the company has not yet formally confirmed it.
Verisk (VRSK) – Nächster Termin für Quartalszahlen
The next expected earnings date for VRSK is October 28, 2026, with the earnings call typically following the company’s quarterly reporting schedule. This report should cover fiscal Q3 2026. If the company changes timing, the date could shift slightly, but late October is the current expected window.
Teradyne (TER) – Nächster Termin für Quartalszahlen
TER’s next earnings date is expected on October 27, 2026. This report should cover Q3 2026. The date is currently an estimated release window based on the company’s historical reporting pattern, since the company has not yet formally confirmed it.
VRSK oder TER in Nemo kaufen
Ohne Provision
Handeln Sie Aktien, ETFs und mehr ohne Provision. Behalten Sie mehr von Ihrer Rendite.
Vertrauenswürdig & reguliert
Seit 2015 Teil der Exinity Group, mit über einer Million Kunden weltweit.
6 % Zinsen auf Guthaben
Erhalten Sie 6 % Zinsen p.a. auf nicht investiertes Guthaben, mit täglicher Zinsgutschrift.
